France: French health tech startup Volta Medical, which is working on novel artificial intelligence algorithms to treat cardiac arrhythmias, today announced that it has successfully raised €23 million. The financing round was led by Gilde Healthcare, with participation by existing shareholder Pasteur Mutualité.
Founded in 2017, Volta Medical has developed one of the first commercially available AI software to help electrophysiologists improve management of cardiac arrhythmias, Volta Medical is now preparing to transform the way ablation procedures will take place in the future.
Theophile Mohr-Durdez, CEO and co-founder of Volta Medical mentioned: “We are excited to be able to complete our highly ambitious medical program with the start of TAILORED-AF, a new randomized controlled trial (RCT). This trial aims to demonstrate how our AI software can help physicians optimize both efficacy and efficiency when performing complex procedures to treat heart rhythm disturbances.”
The fresh funds will allow the company to establish its revolutionary software solution as a new standard of care, pursue further R&D activities, and start to roll out commercial activities across the US and Europe.